Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,943
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
for
Obesity or Overweight
Location: Southlake TX, Dallas TX, Shavano Park TX, Houston TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07351045
Phase 3, Recruiting
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
for
Macular Edema
Location: Southlake TX, Dallas TX, Austin TX, The Woodlands TX,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06962839
Phase 2, Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma,
Location: Grapevine TX, Denison TX, Austin TX, San Antonio TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07221149
Phase 2, Phase 3, Recruiting
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
for
Bronchiectasis With Pseudomonas Aeruginosa Colonization
Location: Mansfield TX, Kansas City KS, St Louis MO, Rincon GA,
Sponsor: AstraZeneca
Sex: All
Age: 12+
Code: NCT07088926
Phase 2, Recruiting
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension
for
Difficult to Control Hypertension
Location: Mansfield TX, Dallas TX, Plano TX, Denton TX,
Sponsor: E-Star BioTech, LLC
Sex: All
Age: 18 - 70+
Code: NCT06343298
Phase 2, Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
for
Inflammatory Bowel Diseases, Crohn's Disease
Location: Mansfield TX, Lewisville TX, Tyler TX, Cedar Park TX,
Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Sex: All
Age: 18 - 70+
Code: NCT06226883
Phase 2, Recruiting
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
for
Depression, Bipolar I Disorder
Location: Mansfield TX, Coppell TX, Plano TX, Dallas TX,
Sponsor: AbbVie
Sex: All
Age: 10 - 17
Code: NCT04777357
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
for
Weight Management
Location: Irving TX, Dallas TX, Oklahoma City OK, Humble TX,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07667803
Phase 3, Recruiting
A Study of DS5361b in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Irving TX, San Antonio TX, Sarasota FL, Fairfax VA,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT07182591
Phase 1, Recruiting
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
for
Major Depressive Disorder (MDD),
Location: Irving TX, Dallas TX, Richardson TX, Chino CA,
Sponsor: Seaport Therapeutics
Sex: All
Age: 18 - 65
Code: NCT07065240
Phase 2, Recruiting
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
for
Breast Cancer, Early Breast Cancer
Location: Irving TX, Pierre SD, Aberdeen SD, Winston-Salem NC
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT05774951
Phase 3, Recruiting
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
for
Focal Segmental Glomerulosclerosis
Location: Grand Prairie TX, Dallas TX, Conroe TX, Shreveport LA,